TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
KURA

Kura Oncology Inc

Healthcare · Biotechnology

10.90$ -1.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Kura Oncology Inc (KURA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 21 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement KURA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
0.0 1.3 0.0 0.0 0.0 54 14 15 21 17 18 21 77
0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 3.2 0.5 0.6 0.2 4.5
-0.2 -0.2 -0.2 -0.2 -0.2 54 14 15 18 17 18 21 73
29 33 36 40 42 52 56 63 68 64 65 62 259
13 14 18 17 18 24 23 25 33 39 32 32 135
42 47 54 56 60 76 79 88 98 104 96 94 391
-42 -47 -54 -56 -60 -22 -65 -73 -80 -86 -79 -73 -318
0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.3 1.4
-39 -43 -50 -51 -54 -17 -57 -66 -74 -81 -73 -68 -297
0.4 2.9 0.2 – – 2.0 0.2 – – 0.1 0.0 0.0 –
-39 -43 -50 -51 -54 -19 -57 -66 -74 -81 -73 -68 -297
-38 -42 -49 -50 -54 -17 -57 -66 -74 -80 -73 -66 -292

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?